ARS Pharmaceuticals, Inc. (SPRY) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$2,126
Total Return
-78.74%
CAGR
-26.63%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.02% |
| Median | +0.53% |
| Best | +63.89% |
| Worst | -59.56% |
| % of Windows Positive | 51.1% |
1-Year (252 Trading Days)
| Average | +29.44% |
| Median | +24.90% |
| Best | +409.91% |
| Worst | -91.90% |
| % of Windows Positive | 58.3% |
3-Year (756 Trading Days)
| Average | +93.37% |
| Median | +64.40% |
| Best | +384.12% |
| Worst | -77.98% |
| % of Windows Positive | 75.8% |
Risk Metrics
| Maximum Drawdown | -92.55% |
| Average Drawdown | -73.25% |
| Drawdown Duration | 1253 Trading Days (Unrecovered) |
| Sortino Ratio | 0.02 |
| Calmar Ratio | -0.29 |
| CVaR (5%) | -10.30% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -30.13% (-71.61% ann.) | $3012.88 | $0.00 | $0.00 | $0.00 |
| 2025 | +10.43% | +$1042.65 | $0.00 | $0.00 | $0.00 |
| 2024 | +92.52% | +$9251.82 | $0.00 | $0.00 | $0.00 |
| 2023 | -35.76% | $3575.62 | $0.00 | $0.00 | $0.00 |
| 2022 | +28.08% | +$2807.81 | $0.00 | $0.00 | $0.00 |
| 2021 | -85.63% | $8562.80 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +85.36% (+422238.98% ann.) | +$8536.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Reopening reflation / fiscal boom / supply bottlenecks partial | December 4, 2020 – November 29, 2021 | -72.12% | -72.63% | $7212.00 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -13.80% | -14.59% | $1379.80 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +117.50% | +52.08% | +$11750.00 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -42.06% | -29.39% | $4206.41 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.